Ajanta Pharma (NSE:AJANTPHARM) Debt-to-Asset : 0.01 (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Debt-to-Asset?

Ajanta Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹113 Mil. Ajanta Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹215 Mil. Ajanta Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₹47,905 Mil. Ajanta Pharma's debt to asset for the quarter that ended in Sep. 2024 was 0.01.

Ajanta Pharma Debt-to-Asset Historical Data

The historical data trend for Ajanta Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Debt-to-Asset Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.02

0.01

Ajanta Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.01	-	0.01	-	0.01

Competitive Comparison of Ajanta Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ajanta Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Debt-to-Asset falls into.

Ajanta Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Ajanta Pharma's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(117.6	+	235.2)	/	46383.9
	=	0.01

Ajanta Pharma's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(112.5	+	215.4)	/	47905
	=	0.01

Ajanta Pharma (NSE:AJANTPHARM) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Ajanta Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajanta Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (NSE:AJANTPHARM) » Definitions » Debt-to-Asset

Traded in Other Exchanges

532331:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a presence while generating the vast majority of its revenue in India. The company aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, creams, injectables, capsules, liquids, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma Headlines

No Headlines